Aurora Hires Former GeneProt Exec as VP, Business Development | GenomeWeb

NEW YORK, March 23 – Aurora Biosciences said it has hired William Ettouati, former co-CEO of Geneva Proteomics, as vice president of business development.

Ettouati, who was at the helm of Geneva Proteomics from April to August of last year, will seek to expand Aurora’s business in Europe and develop other strategic alliances, Aurora said. Before his term at GeneProt, Ettouati headed up Ceptyr, a Seattle-based biotech company developing PTP-based therapeutics. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.